Sarah Monroe once had a relatively comfortable middle-class life. She and her family lived in a neatly landscaped neighborhood near Cleveland. They had a six-figure income and health insurance. Then, four years ago, when Monroe was pregnant with twin girls, something started to feel off. “I kept having to come into the emergency room for…
Stryker was hit by a cyberattack this week that knocked out its internal systems worldwide and caused delays to order processing and manufacturing. An Iran-linked group has claimed responsibility for the attack, but the full impact remains unclear. The post 6 Things to Know About Stryker’s Cyberattack appeared first on MedCity News.
Ensuring buy-in from end users is critical to hospitals’ AI success. To achieve buy-in, hospitals should start by adopting AI tools that address the problems that physicians and nurses have identified as most important to them, said Rohit Chandra, chief digital officer at Cleveland Clinic. The post Cleveland Clinic Digital Chief: Pick AI Problems That…
Cohere Health raked in $90 million in Series C capital, taking its total funding to date to $200 million. This round of funding cements Cohere as the emerging winner in the prior authorization tech category, according to Michael Greeley, general partner at Flare Capital Partners. The post Cohere Health Snags $90M to Automate the Much-Maligned…
For other IV fluids still in short supply, the FDA is working with manufacturers to monitor the supply, FDA Commissioner states
I got to interview V Bento the CEO of Sword Health. We had been in a little back and forth on Linkedin but this was the first time we actually had talked. Almost all of their business is in the US in MSK but they have recently added mental health and V is not shy…
Equity has to be built into the deployment strategy from day one, not treated as a future retrofit. That means prioritizing inclusion not only in the data but in the delivery, and recognizing that inclusive deployment is the foundation for inclusive datasets. The post Bias Doesn’t End at the Dataset: It Lives in the Deployment…
By GEORGE BEAUREGARD During my years in a bustling metropolitan primary care practice from 1992 to 2010, I recall only a handful of patients under 50 who developed cancer. Not surprisingly, these were mostly cases of Hodgkin’s and Non-Hodgkin’s lymphomas, myeloma, skin, and breast cancer. Fortunately, those few patients were wearing the mantle of cancer…
The non-responder gap matters for two reasons: First, patients who are in an advanced stage of cancer lose valuable time in ineffective therapy. Second, it increases the cost of therapy and resources for both patients and the broader healthcare ecosystem. The post An AI Driven Approach to Address the Non-Responder Gap in Radiopharmaceutical Therapy appeared…
Prior authorizations continue to challenge healthcare organizations as payer authorization requirements expand and change. Automated prior authorizations can bring new efficiency and consistency to a process that’s ripe for evolution, but how will providers make the leap? Alicia Pickett, Senior Product Manager at Experian Health, shares her perspectives on the issues providers are talking about…